GT Biopharma Inc

GTBP

Company Profile

  • Business description

    GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.

  • Contact

    315 Montgomery Street
    10th Floor
    San FranciscoCA94104
    USA

    https://www.gtbiopharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    1

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,652.2027.300.32%
CAC 407,788.1038.69-0.49%
DAX 4024,038.19188.30-0.78%
Dow JONES (US)42,098.70244.95-0.58%
FTSE 1008,726.0152.04-0.59%
HKSE23,315.8657.550.25%
NASDAQ19,100.9498.22-0.51%
Nikkei 22538,355.70633.301.68%
NZX 50 Index12,297.7864.48-0.52%
S&P 5005,888.5532.99-0.56%
S&P/ASX 2008,425.1028.200.34%
SSE Composite Index3,361.8321.900.66%

Market Movers